Sara E. Sims, Ph.D.

Sara E. Sims, Ph.D.

Practice Areas
  • Pennsylvania State University, BS, Biochemistry and Molecular Biology, 2005
  • The Johns Hopkins University, PhD, Biochemistry and Molecular Biology, 2010
  • Harvard University Medical School, Post doc, Genetics, 2011-2015
Bar Admissions

U.S. Patent and Trademark Office

Sara E. Sims, Ph.D. Patent Agent

Philadelphia: 215.965.1291   F: 215.965.1331   E:

Dr. Sara E. Sims is a patent agent who assists in the preparation, filing and prosecution of patent applications, as well as conducting searches and reviews for due diligence, patentability and freedom to operate analyses. She provides technical support and scientific expertise to assist with all aspects of patent protection, both US and foreign, focusing on the pharmaceutical and biotechnical arts.

Prior to joining Panitch Schwarze Belisario & Nadel LLP, Dr. Sims was a postdoctoral fellow at Harvard University, where she used combined genetic, molecular biology, cytology and biochemistry techniques to gain insight into the roles of histone-modifying enzymes in promoting accurate meiotic cell division in C. elegans. As a graduate student, she worked in a yeast genetics lab, where she characterized the function and regulation of a pair of novel proteins as potential antifungal drug targets. During her undergraduate studies, Dr. Sims worked as a research assistant in a lab studying transcription regulation in E. coli.

Dr. Sims received her B.S. in Biochemistry and Molecular Biology with a minor in Chemistry from the Schreyer Honors College at Pennsylvania State University and her Ph.D. in Biochemistry and Molecular Biology from The Johns Hopkins University. She had four years of postdoctoral research experience in genetics and molecular biology at Harvard University Medical School, where she received a Ruth L. Kirschstein Postdoctoral Fellowship from the National Institutes of Health.

Articles & Presentations

Panitch Schwarze Presents Patent Due Diligence CLE // February 18, 2016
A Patent Due Diligence CLE on IP due diligence including freedom to operate, IP portfolio assessment, patentability/validity analysis, ownership, and IP related agreements. Read more

Panitch Schwarze Expands Pharmaceutical and Biotechnology IP Practice // February 11, 2015
Panitch Schwarze Belisario and Nadel LLP continues to build on the strength of its Pharmaceutical and Biotechnology practices with the addition of Scientific Advisor, Dr. Sara E. Sims. Read more


Email Disclaimer

Sending an email to our office does not create an attorney-client relationship, and none will be formed unless there is an expressed agreement between the firm and the client. Thus, we strongly advise against sending confidential or privileged information to us until you can establish such a relationship. Furthermore, we advise against sending privileged or confidential information through email at all, since we can in no way ensure the security of your email. In fact, neither this website nor the email system involved is encrypted, so you should not assume that your email is confidential. We cannot guarantee that someone else will not see it.

Do you agree to this Email Disclaimer?

I Agree I Do Not Agree